Abstract
Background: The aim of this study is to compare the prognostic impact of 2 precursor lesions of ampullary adenocarcinoma, intra-ampullary papillary-tubular neoplasm (IAPN) and flat dysplasia (FD). Methods: From December 1994 to December 2012, a total of 359 patients underwent curative surgery for ampullary adenocarcinoma. Results: The precursor lesions were IAPNs in 134 (37.3%) patients and FD in the other 225 (62.7%) patients. The FD group had more aggressive tumor biology with advanced T stage (p = 0.002), nodal involvement (p < 0.001), poor differentiation (p < 0.001), perineural and lymphovascular invasion (p < 0.001), and pancreatobiliary or mixed subtype (p < 0.001). Five-year overall survival rates were 71.1% in the IAPN group and 51.4% in the FD group (p = 0.002), respectively. Five-year disease-free survival rates were 69.7% in the IAPN group and 49.6% in the FD group (p < 0.001), respectively. The recurrence rate was also higher in the FD group (49.8 vs. 30.6%; p < 0.001). On multivariate analysis, higher levels of tumor markers including CEA and CA19-9, lymph node metastasis, poorly differentiated histology, and perineural invasion were negative predictive factors for survival. Higher levels of CEA and CA19-9, lymphovascular invasion, and FD were independent prognostic factors for recurrence. Conclusion: FD was significantly associated with worse prognosis and a greater tendency toward advanced disease. Further studies are needed to clarify the impacts of these precursor lesions.
References
1.
Howe
JR
, Klimstra
DS
, Moccia
RD
, Conlon
KC
, Brennan
MF
. Factors predictive of survival in ampullary carcinoma
. Ann Surg
. 1998 Jul
;228
(1
):87
–94
. 2.
Yeo
CJ
, Sohn
TA
, Cameron
JL
, Hruban
RH
, Lillemoe
KD
, Pitt
HA
. Periampullary adenocarcinoma: analysis of 5-year survivors
. Ann Surg
. 1998 Jun
;227
(6
):821
–31
. 3.
Winter
JM
, Cameron
JL
, Olino
K
, Herman
JM
, de Jong
MC
, Hruban
RH
, et al Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis
. J Gastrointest Surg
. 2010 Feb
;14
(2
):379
–87
. 4.
Kimura
W
, Futakawa
N
, Yamagata
S
, Wada
Y
, Kuroda
A
, Muto
T
, et al Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater
. Jpn J Cancer Res
. 1994 Feb
;85
(2
):161
–6
. 5.
Kimura
W
, Futakawa
N
, Zhao
B
. Neoplastic diseases of the papilla of Vater
. J Hepatobiliary Pancreat Surg
. 2004
;11
(4
):223
–31
. 6.
Zhou
H
, Schaefer
N
, Wolff
M
, Fischer
HP
. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up
. Am J Surg Pathol
. 2004 Jul
;28
(7
):875
–82
. 7.
Baczako
K
, Büchler
M
, Beger
HG
, Kirkpatrick
CJ
, Haferkamp
O
. Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma
. Hum Pathol
. 1985 Mar
;16
(3
):305
–10
. 8.
Talbot
IC
, Neoptolemos
JP
, Shaw
DE
, Carr-Locke
D
. The histopathology and staging of carcinoma of the ampulla of Vater
. Histopathology
. 1988 Feb
;12
(2
):155
–65
. 9.
Ohike
N
, Kim
GE
, Tajiri
T
, Krasinskas
A
, Basturk
O
, Coban
I
, et al Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases
. Am J Surg Pathol
. 2010 Dec
;34
(12
):1731
–48
. 10.
American Joint Committee on Cancer
. AJCC cancer staging manual
. 7th ed. New York
: Springer-Verlag
; 2010
.11.
Albores-Saavedra
J
, Henson
DE
, Klimstra
DS
. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater
. In: Rosai
J
, Sobin
L
, editors. Atlas of tumor pathology
. Washington, DC
: Armed Forces Institute of Pathology
; 2000
. Vol. 3
; p. 259
–316
.12.
Kim
RD
, Kundhal
PS
, McGilvray
ID
, Cattral
MS
, Taylor
B
, Langer
B
, et al Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma
. J Am Coll Surg
. 2006 Jan
;202
(1
):112
–9
. 13.
Sarmiento
JM
, Nagomey
DM
, Sarr
MG
, Farnell
MB
. Periampullary cancers: are there differences?
Surg Clin North Am
. 2001 Jun
;81
(3
):543
–55
. 14.
Beger
HG
, Treitschke
F
, Gansauge
F
, Harada
N
, Hiki
N
, Mattfeldt
T
. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients
. Arch Surg
. 1999 May
;134
(5
):526
–32
. 15.
Talamini
MA
, Moesinger
RC
, Pitt
HA
, Sohn
TA
, Hruban
RH
, Lillemoe
KD
, et al Adenocarcinoma of the ampulla of Vater. A 28-year experience
. Ann Surg
. 1997 May
;225
(5
):590
–600
; discussion 599–600. 16.
Carter
JT
, Grenert
JP
, Rubenstein
L
, Stewart
L
, Way
LW
. Tumors of the ampulla of Vater: histopathologic classification and predictors of survival
. J Am Coll Surg
. 2008 Aug
;207
(2
):210
–8
. 17.
Qiao
QL
, Zhao
YG
, Ye
ML
, Yang
YM
, Zhao
JX
, Huang
YT
, et al Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection
. World J Surg
. 2007 Jan
;31
(1
):137
–46
; discussion 144–6
. 18.
Barauskas
G
, Gulbinas
A
, Pranys
D
, Dambrauskas
Z
, Pundzius
J
. Tumor-related factors and patient’s age influence survival after resection for ampullary adenocarcinoma
. J Hepatobiliary Pancreat Surg
. 2008
;15
(4
):423
–8
. 19.
Chang
DK
, Jamieson
NB
, Johns
AL
, Scarlett
CJ
, Pajic
M
, Chou
A
, et al Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater
. J Clin Oncol
. 2013 Apr 1
;31
(10
):1348
–56
. 20.
Roh
YH
, Kim
YH
, Lee
HW
, Kim
SJ
, Roh
MS
, Jeong
JS
, et al The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis
. Hepatogastroenterology
. 2007 Sep
;54
(78
):1641
–4
.21.
Sikora
SS
, Balachandran
P
, Dimri
K
, Rastogi
N
, Kumar
A
, Saxena
R
, et al Adjuvant chemo-radiotherapy in ampullary cancers
. Eur J Surg Oncol
. 2005 Mar
;31
(2
):158
–63
. 22.
Klinkenbijl
JH
, Jeekel
J
, Sahmoud
T
, van Pel
R
, Couvreur
ML
, Veenhof
CH
, et al Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group
. Ann Surg
. 1999 Dec
;230
(6
):776
–84
; discussion 782–4. 23.
Neoptolemos
JP
, Moore
MJ
, Cox
TF
, Valle
JW
, Palmer
DH
, McDonald
AC
, et al Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial
. JAMA
. 2012 Jul 11
;308
(2
):147
–56
. 24.
Rostain
F
, Hamza
S
, Drouillard
A
, Faivre
J
, Bouvier
AM
, Lepage
C
. Trends in incidence and management of cancer of the ampulla of Vater
. World J Gastroenterol
. 2014 Aug 7
;20
(29
):10144
–50
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
